WealthTrust Axiom’s Tandem Diabetes Care TNDM Stock Holding History

WealthTrust Axiom’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,000	Closed	-$236K	–	256
2022 Q2	$236K	Hold	4,000	–	–	0.08%	196
2022 Q1	$465K	Sell	4,000 -1,000	-20%	-$117K	0.15%	140
2021 Q4	$752K	Hold	5,000	–	–	0.24%	93
2021 Q3	$596K	Sell	5,000 -1,000	-17%	-$110K	0.2%	107
2021 Q2	$584K	Hold	6,000	–	–	0.19%	111
2021 Q1	$529K	Hold	6,000	–	–	0.18%	114
2020 Q4	$574K	Hold	6,000	–	–	0.21%	103
2020 Q3	$681K	Hold	6,000	–	–	0.29%	74
2020 Q2	$593K	Hold	6,000	–	–	0.26%	86
2020 Q1	$386K	Hold	6,000	–	–	0.19%	98
2019 Q4	$357K	Hold	6,000	–	–	0.12%	129
2019 Q3	$353K	Hold	6,000	–	–	0.12%	134
2019 Q2	$387K	Hold	6,000	–	–	0.13%	126
2019 Q1	$381K	Hold	6,000	–	–	0.14%	130
2018 Q4	$227K	Hold	6,000	–	–	0.09%	169
2018 Q3	$257K	Buy	+6,000	New	+$210K	0.09%	180

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WealthTrust Axiom's TNDM Position: Q3 2022 in Review

WealthTrust Axiom sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 4,000 shares — an estimated $236K sold.

WealthTrust Axiom first reported a position in TNDM in Q3 2018 and held it in 16 quarters. The position peaked at $752K in Q4 2021. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

WealthTrust Axiom reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
WealthTrust Axiom sold 4,000 Tandem Diabetes Care shares in Q3 2022, an estimated $236K.
WealthTrust Axiom first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 16 quarters.
WealthTrust Axiom's Tandem Diabetes Care position peaked at $752K in Q4 2021.
299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on WealthTrust Axiom's 13F filing for Q3 2022, filed 3 Nov 2022.